Short Communication
Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients

https://doi.org/10.1016/j.jcf.2011.09.006Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

The clinical course of cystic fibrosis (CF) lung disease varies between patients bearing identical CFTR mutations. This suggests that additional genetic modifiers may contribute to the pulmonary phenotype. The highly conserved ancestral haplotype 8.1 (8.1AH), carried by up to one quarter of Caucasians, comprises linked gene polymorphisms on chromosome 6 that play a key role in the inflammatory response: LTA + 252A/G; TNF −308G/A, HSP70-2 + 1267A/G and RAGE −429T/C. As inflammation is a key component inducing CF lung damage, we investigated whether the 8.1AH represents a lung function modifier in CF.

Methods

We analyzed the lung function of 404 European CF patients from France (n = 230), Germany (n = 95) and UK (n = 79). FEV1 differences between 8.1AH carriers and non-carriers were calculated in each country and pooled using a random effects model.

Results

The frequency of 8.1AH carriers was similar between French (22%), German (29%) and UK (27%) patients. We found that 8.1AH carriers had significantly lower FEV1, adjusted for age classes and countries (P < 0.04, mean FEV1 difference − 6.4% CI95% [− 12.4%, − 0.5%]). No difference was observed with respect to BMI Z-scores and chronic colonization with P. aeruginosa.

Conclusions

These findings support the concept that 8.1AH is an important genetic modifier of lung disease in CF. To conclude, multiple linked genes outside the CF locus might explain some of the variability in lung phenotype.

Keywords

Cystic fibrosis
8.1 Ancestral Haplotype
Modifier genes
Lung function

Cited by (0)

These data have been presented in conferences: NACFC 2010—Baltimore (Pediatric Pulmonology 2010, supplement 33: abstract page 282) and ECFC 2011—Hamburg (invited talk—genetics symposium).

1

Equally contributed.